FEDERATED HERMES, INC. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,376,486
-60.8%
8,981,717
-21.2%
0.06%
-58.1%
Q2 2023$54,581,097
-37.0%
11,394,801
-25.4%
0.14%
-37.6%
Q1 2023$86,622,609
-14.5%
15,277,356
-15.5%
0.22%
-22.1%
Q4 2022$101,281,253
-14.7%
18,085,938
-2.2%
0.28%
-19.5%
Q3 2022$118,765,000
+92.6%
18,499,136
+2.9%
0.35%
+107.1%
Q2 2022$61,679,000
+8.1%
17,982,256
+124.5%
0.17%
+30.2%
Q1 2022$57,037,000
-1.0%
8,010,806
+15.9%
0.13%
+20.6%
Q4 2021$57,595,000
+15.2%
6,914,136
-3.7%
0.11%
+12.6%
Q3 2021$49,987,000
-10.7%
7,182,100
+205.9%
0.10%
-8.7%
Q2 2021$55,998,000
-1.6%
2,347,909
-15.0%
0.10%
-5.5%
Q1 2021$56,888,000
-21.4%
2,762,909
-6.4%
0.11%
-25.7%
Q4 2020$72,350,000
-8.4%
2,953,070
+5.9%
0.15%
-20.0%
Q3 2020$78,976,000
+1512.7%
2,789,667
+171.2%
0.18%
+1441.7%
Q2 2020$4,897,000
+33.3%
1,028,8000.0%0.01%
+9.1%
Q1 2020$3,673,000
+169.1%
1,028,800
+160.0%
0.01%
+266.7%
Q4 2019$1,365,000
-17.6%
395,665
-4.2%
0.00%
-25.0%
Q3 2019$1,657,000
+27516.7%
413,121
+21563.4%
0.00%
Q2 2019$6,000
-70.0%
1,907
-34.1%
0.00%
Q1 2019$20,000
-99.7%
2,894
-99.8%
0.00%
-100.0%
Q4 2018$7,861,000
-41.5%
1,739,228
-1.8%
0.02%
-32.3%
Q3 2018$13,436,000
-11.7%
1,770,255
+0.0%
0.03%
-31.1%
Q2 2018$15,221,000
+17.4%
1,769,839
+0.2%
0.04%
+18.4%
Q1 2018$12,968,000
-14.5%
1,766,681
+18.1%
0.04%
-11.6%
Q4 2017$15,174,000
+21.4%
1,496,457
+92.1%
0.04%
+19.4%
Q3 2017$12,496,000
+47.7%
779,006
+4.1%
0.04%
+50.0%
Q2 2017$8,459,000
-5.9%
748,568
-6.1%
0.02%
-7.7%
Q1 2017$8,988,000
-18.4%
797,484
-28.3%
0.03%
-21.2%
Q4 2016$11,016,000
-56.1%
1,112,712
-45.6%
0.03%
-54.2%
Q3 2016$25,116,000
-56.6%
2,043,578
+2.6%
0.07%
-57.4%
Q2 2016$57,837,000
+109.7%
1,990,934
+91.7%
0.17%
+96.5%
Q1 2016$27,578,000
+13.1%
1,038,332
+49.4%
0.09%
+11.7%
Q4 2015$24,387,000
+43.8%
694,980
+21.5%
0.08%
+40.0%
Q3 2015$16,954,000572,0000.06%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders